Denali Therapeutics holder plans $36.9K stock sale

Form 144 covers 1,654 DNLI shares from vested RSUs, with sales intended to satisfy related tax obligations.

Rhea-AI Filing Summary

Denali Therapeutics Inc. (DNLI) is the subject of a Form 144 notice filed for the potential sale of 1,654 shares of its common stock by stockholder Chin Peter Scott through Morgan Stanley Smith Barney LLC. The shares relate to vested Restricted Stock Units, and the filer notes that shares are being sold to cover a tax obligation from the settlement of those awards.

Key Figures

Shares covered by Form 144: 1,654 shares Aggregate market value: $36,867.14 Date of Notice: September 4, 2026 +1 more

4 metrics

Shares covered by Form 144 1,654 shares Common stock of Denali Therapeutics Inc. referenced in the notice

Aggregate market value $36,867.14 Value associated with the 1,654 shares of common stock

Date of Notice September 4, 2026 Date shown in the signature section of the Form 144

Shares from equity compensation event 1,654 shares Shares tied to Restricted Stock Units with a restricted stock lapse on September 3, 2026

Key Terms

Rule 144, Restricted Stock Units, Equity Compensation, Restricted Stock Lapse

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Shares sold to cover tax obligation from settlement of vested Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Compensation financial

"1654 | 09/03/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Restricted Stock Lapse financial

"Restricted Stock Lapse - See Remarks"

FAQ

What does the Form 144 filing for DNLI disclose?

It discloses a planned sale of 1,654 shares of Denali Therapeutics Inc. common stock by Chin Peter Scott under Rule 144, with shares associated with vested Restricted Stock Units and intended to cover a related tax obligation.

How many DNLI shares are covered by this Form 144 notice?

The notice covers up to 1,654 shares of Denali Therapeutics Inc. common stock. This is the amount listed under securities information and securities to be sold for the relevant transaction.

What is the approximate aggregate value of DNLI shares in this Form 144?

The securities information section lists an aggregate value of $36,867.14 for the 1,654 shares of Denali Therapeutics Inc. common stock referenced in the Form 144 notice.

Why are DNLI shares being sold according to the Form 144 remarks?

The remarks state that shares were sold to cover tax obligation from the settlement of vested Restricted Stock Units, indicating the sale is tied to equity compensation–related taxes.

When was the Form 144 notice for DNLI dated?

The Form 144 notice is dated September 4, 2026, which appears in the Date of Notice field in the signature section signed by Tyler Nielsen by power of attorney.

Which broker is listed for the DNLI Form 144 transaction?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, associated with the 1,654 shares of Denali Therapeutics Inc. common stock referenced in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 08:39 PM Accepted by SEC EDGAR 09/04/2026 - 08:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002124755
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Denali Therapeutics Inc.
SEC File Number	001-38311
Address of Issuer	161 Oyster Point Blvd South San Francisco CALIFORNIA 94080
Phone	6508668547
Name of Person for Whose Account the Securities are To Be Sold	Chin Peter Scott
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Fl. New York NY 10004	1654	36867.14	160144391	09/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/03/2026	Restricted Stock Lapse - See Remarks	Denali Therapeutics Inc.			1654	09/03/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares sold to cover tax obligation from settlement of vested Restricted Stock Units.
Date of Notice	09/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Tyler Nielsen, by power of attorney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)